BioVie Inc.

BioVie Inc.

BIVIW - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.74M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BioVie Inc.BioVie Inc.-0.4--346%--
$1.20

Current Fair Value

471.9% upside

Undervalued by 471.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.74 Million
Enterprise Value$-5,741,882.00
Earnings per Share$-3.05
Beta0.28
Outstanding Shares8,269,338

Return

Return on Equity-346.02%ROE
Return on Assets-204.66%
Return on Invested Capital-341.21%

Valuation & Multiples

P/E Ratio-0.39P/E Ratio
PEG-4.22PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-0.05
Enterprise Value to Net Income0
Total Debt to Enterprise0.23
Debt to Equity0.04Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 6, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
December 2, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About BioVie Inc

3 employees
CEO: Cuong Viet Do

BioVie Inc. is developing BIV201 (continuous infusion terlipressin) an Orphan Drug candidate for the treatment of ascites due to advanced liver cirrhosis. First-to-market Orphan therapies typically receive 7 years of market exclusivity i...

BioVie Insider Information FAQ

Stockcircle shows 4 open-market insider purchases for BioVie in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.

Questions & Answers